ArticleEuropean heart journal2010
The rise and fall of rosiglitazone.
Article in European heart journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.BMJ (Clinical research ed.) · 2020Pooled it
- The Timeline of the Association Between Diabetes and Cardiovascular Diseases: A Narrative Review.Journal of clinical medicine · 2025Review
- Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent.Molecules (Basel, Switzerland) · 2024Article
- Review
- Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.Clinical trials (London, England) · 2022Article
- Metabolic implications of pancreatic fat accumulation.Nature reviews. Endocrinology · 2022Review
- Cardioprotective Effects of Pioglitazone in Type 2 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2021Article
- Thiazolidinediones: An In-Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus.ChemMedChem · 2021Review
- Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.Pharmaceutics · 2021Article
- Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association.International journal of molecular sciences · 2021Review
- Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).EClinicalMedicine · 2021Article
- Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future.Therapeutic advances in drug safety · 2020Review
- Phytochemical characterization ofJournal of food bioactives : an official scientific publication of the International Society of Nutraceuticals and Functional Foods (ISNFF) · 2018Article
- Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice.Scientific reports · 2018Article
- Interpreting Clinical Trial Outcomes for Optimal Patient Care: A Survey of Clinicians and Trainees.Journal of graduate medical education · 2016Article
- Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.American journal of translational research · 2016Article
- Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.Pharmacoepidemiology and drug safety · 2015Article
- Metformin in Diabetic Patients with Heart Failure: Safe and Effective?Current cardiovascular risk reports · 2013Article
- Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010.BMJ open · 2013Article
- Research ethics. Rethinking research ethics: the case of postmarketing trials.Science (New York, N.Y.) · 2012Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
20154334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.